Investors

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.

Filing date	Description	Form	View
October 20, 2017		D	0001678660-17-000001.pdf 0001678660-17-000001.rtf 0001678660-17-000001.xls View HTML
July 11, 2016		D	0001678660-16-000001.pdf 0001678660-16-000001.rtf 0001678660-16-000001.xls View HTML

Data provided by Kaleidoscope.

Print Page

RSS Feeds

Email Alerts